2021 American Transplant Congress » Hepatitis C

6:00pm-6:05pm

Association of Donor Hepatitis C Virus Infection Status and Risk of Bk Polyomavirus Viremia After Kidney Transplantation

V. S. Potluri¹, D. E. Schaubel¹, M. E. Sise², B. P. Concepcion³, R. C. Forbes¹, E. A. Blumberg¹, D. Goldberg⁴, P. P. Reese¹, R. Bloom¹, D. Shaffer³, R. Chung², D. Sawinski¹, I. Strohben², N. Elias², A. Azhar⁵, M. Shah¹, J. Eason⁵, L. A. Binari³, M. Talwar⁵, V. Balaraman⁵, A. Bhalla⁵, B. Besharatian¹, M. Z. Molnar⁵

6:05pm-6:10pm

Outcomes of Short-Duration Anti-Viral Prophylaxis for Hepatitis C Positive Donor Kidney Transplants

G. Gupta, I. Yakubu, P. Kimball, L. Kang, K. Mitchell, M. Shinbashi, D. Kumar, I. Moinuddin, L. Kamal, A. King, C. Bhati, M. Levy, A. Cotterell, A. Sharma, R. Sterling

6:10pm-6:15pm

Cost-Effectiveness Analysis of Short-Duration Anti-Viral Prophylaxis for Hepatitis C Positive Donor Kidney Transplants

I. Yakubu, Y. Zhang, S. Ijioma, N. V. Carroll, J. Patterson, R. Sterling, G. Gupta

6:15pm-6:20pm

Are Tacrolimus Concentrations Reduced with Direct-acting Antiviral Administration in Transplant Recipients?

K. Huang, K. Farrow, M. Christian

6:20pm-6:25pm

Outcomes of Kidney Transplantation from Hepatitis C Virus (HCV) Infected Donors Stratified by Recipient HCV Serostatus: A Mate Kidney Analysis

K. K. Sureshkumar¹, B. Chopra¹, R. L. McGill²

6:25pm-6:30pm

Outcomes of Hepatitis C Nucleic Acid Testing Positive Donors in Aviremic Recipients With Delayed Direct-Acting Antiviral Initiation

M. Hudson, A. Webb, A. Logan, A. Silverman, A. Brueckner

6:30pm-6:35pm

Transplanting Hepatitis C Infected Organs Into Uninfected Recipients: A Pharmacy Perspective

M. L. Holt, A. James, K. Gutierrez, T. Sparkman, J. Banbury, D. Jones

6:35pm-6:40pm

Use of Donor Blood Expedites HCV Genotyping and Allows Earlier DAA Initiation for Recipients of HCV+ Kidneys

B. Lonze, N. Ali, R. Montgomery, Z. Stewart Lewis